Grifols (GRF.P) AI Stock Analysis

9 Followers

Grifols

(BME:GRF.P)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Negative Factors

Grifols (GRF.P) vs. iShares MSCI Spain ETF (EWP)

Market Cap: EUR 6.80B
Dividend Yield: 2.52%
Average Volume (3M): 101.55K
Price to Earnings (P/E): 10.9
Beta (1Y): 0.70
Revenue Growth: 1.03%
EPS Growth: 30.59%
Country: Spain
Employees: 23,737
Sector: General
Sector Strength: 55
Industry: Pharmaceuticals

Grifols Business Overview & Revenue Model

Company Description

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portf...

Grifols Risk Analysis

Grifols disclosed 53 risk factors in its most recent earnings report. Grifols reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Grifols Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

ES:GRF.P against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ES:ROVI	77Outperform	EUR 3.51B	17.59	29.17%	1.36%	14.41%	69.69%
ES:ALM	65Neutral	EUR 2.30B	32.54	4.78%	1.71%	9.67%	174.00%
ES:FAE	64Neutral	EUR 1.53B	11.50	18.19%	2.56%	31.88%	-20.09%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
ES:RJF	47Neutral	EUR 212.43M	30.81	3.14%	0.74%	-0.42%	4.56%

* General Sector Average

Performance Comparison

ES:GRF.P and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
ES:GRF.P	Grifols, SA	7.86	0.31	4.08%
ES:ALM	Almirall SA	10.78	-1.40	-11.49%
ES:FAE	Faes Farma	5.00	0.47	10.28%
ES:RJF	LABORATORIO REIG JOFRE	2.61	-0.13	-4.71%
ES:ROVI	Laboratorios Farmaceuticos Rovi	70.70	12.67	21.83%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Grifols AI Stock Analysis